Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Journal of the American College of Cardiology - 1 Nov 2000

Ballantyne C M, Herd J A, Stein E A, Ferlic L L, Dunn J K, Gotto A M, Marian A J

Abstract excerpt

OBJECTIVES: We sought to examine the association of apolipoprotein (apo) E genotypes with baseline plasma lipid levels and severity of coronary artery disease (CAD), as well as the response to treatment with fluvastatin in the Lipoprotein and Coronary Atherosclerosis Study (LCAS). BACKGROUND: Apo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Apolipoproteins E
Share to Cholesterol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Disease Progression

Share to Fatty Acids, Monounsaturated

Share to Indoles

Share to Remission Induction

Source

Identifiers

PMID: 11079660
DOI: 10.1016/s0735-1097(00)00918-9

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11079660-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.PMID 11079660Read ↗

Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.Semantic proximity Read ↗

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease.Semantic proximity Read ↗

Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol.Semantic proximity Read ↗

Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.Semantic proximity Read ↗

Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapy.Semantic proximity Read ↗

Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.Semantic proximity Read ↗

Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).Semantic proximity Read ↗

Identification of genetic variants associated with response to statin therapy.Semantic proximity Read ↗

Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart DiseaseSemantic proximity Read ↗

Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype.Semantic proximity Read ↗

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.Semantic proximity Read ↗

APOE gene polymorphisms and response to statin therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.